<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-HKZNZLBQ</identifier><date>2011</date><creator>Herman, Ana</creator><creator>Jeras, Matjaž</creator><relation>documents/doc/H/URN_NBN_SI_doc-HKZNZLBQ_001.htm</relation><relation>documents/doc/H/URN_NBN_SI_doc-HKZNZLBQ_001.pdf</relation><relation>documents/doc/H/URN_NBN_SI_doc-HKZNZLBQ_001.txt</relation><format format_type="issue">3</format><format format_type="volume">62</format><format format_type="type">article</format><format format_type="extent">str. 123-130</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">3066737</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-HKZNZLBQ</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">celično imunsko zdravljenje</subject><subject language_type_id="slv">dendritične celice</subject><subject language_type_id="slv">imunohibridomi</subject><subject language_type_id="slv">imunologija</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">rak (medicina)</subject><title>Cellular immunotherapies of cancer</title><title>Zdravljenje raka z imunskimi celicami</title></Record>